Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 20/20 | 0.85 |
| ▸ | IL6 | P05231 | 4/20 | 0.51 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27249516 | 1.00 | TLR7 (0.85) | TLR7IL6NUDT1 | |
| SCHEMBL27249641 | 0.92 | TLR7 (1.00) | TLR7IL6 | |
| SCHEMBL27249640 | 0.92 | TLR7 (1.00) | TLR7IL6 | |
| SCHEMBL30747687 | 0.92 | TLR7 (1.00) | TLR7IL6 | |
| SCHEMBL30747764 | 0.92 | TLR7 (1.00) | TLR7IL6 | |
| SCHEMBL1146668 | 0.86 | TLR7 (0.72) | TLR7IL6NUDT1 | |
| SCHEMBL30323751 | 0.85 | TLR7 (0.74) | TLR7IL6 | |
| SCHEMBL1146385 | 0.85 | TLR7 (0.74) | TLR7IL6 | |
| SCHEMBL20756317 | 0.85 | TLR7 (0.73) | TLR7IL6 | |
| SCHEMBL30747794 | 0.84 | TLR7 (0.83) | TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024013205-A9 | PHOSPHORYLPURINONE COMPOUNDS FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2025-04-10 | — | — | WO | claimed |
| EP-4554678-A1 | PHOSPHORYLPURINONE COMPOUNDS FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2025-05-21 | — | — | EP | disclosed |
| WO-2024013205-A9 | PHOSPHORYLPURINONE COMPOUNDS FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2025-04-10 | — | — | WO | disclosed |
| WO-2024013205-A1 | PHOSPHORYLPURINONE COMPOUNDS FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2024-01-18 | — | — | WO | disclosed |